Racial disparities in cervical cancer survival over time

Cancer

Volumn 119, Issue 20, 2013, Pages 3644-3652

  Rauh Hain, J Alejandro ^a   Clemmer, Joel T ^a   Bradford, Leslie S ^a   Clark, Rachel M ^a   Growdon, Whitfield B ^a   Goodman, Annekathryn ^a   Boruta II, David M ^a   Schorge, John O ^a   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

African American; cervical cancer; disparities; race; SEER

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; METASTASIS; PRIORITY JOURNAL; RACE DIFFERENCE; UTERINE CERVIX CANCER;

AFRICAN AMERICAN; CERVICAL CANCER; DISPARITIES; RACE; SEER;

ADENOCARCINOMA; AFRICAN AMERICANS; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84885183476     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28261     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011; 103: 714-736.
3. Howlader N, Noone A, Krapcho M, et al. editors. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
4. Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010; 116: 2531-2542.
5. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55: 10-30. (Pubitemid 40310185)
6. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
7. Terplan M, Schluterman N, McNamara EJ, Tracy JK, et al. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol. 2012; 125: 19-24.
8. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2012: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2012; 61: 212-236.
9. Patel DA, Barnholtz-Sloan JS, Patel MK, et al. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005; 97: 550-558. (Pubitemid 40614903)
10. Adams SA, Fleming A, Brandt HM, et al. Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina. J S C Med Assoc. 2009; 105: 237-244.
11. Del Carmen MG, Avila-Wallace M,. Effect of health care disparities on screening. Clin Obstet Gynecol. 2013; 56: 65-75.
12. Howell EA, Chen YT, Concato J,. Differences in cervical cancer mortality among Black and White women. Obstet Gynecol. 1999; 94: 509-515. (Pubitemid 29460931)
13. Brooks SE, Baquet CR, Gardner JF, et al. cervical cancer-the impact of clinical presentation, health and race on survival. J Assoc Acad Minor Phys. 2000; 11: 55-59.
14. Hicks ML, Yap OW, Matthews R, Parham G,. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006; 16 (2 suppl 3): S3-63-6.
15. Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African American women with cervical carcinoma. Cancer. 2001; 91: 869-873. (Pubitemid 32173314)
16. Ferrante JM, Gonzalez EC, Roetzheim RG, et al. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med. 2000; 9: 439-445.
17. Riley GF, Potosky AL, Lubitz JD, Brown ML,. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994; 84: 1598-1604. (Pubitemid 24323416)
18. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001; 33: 1 90-203. (Pubitemid 32802722)
19. Dignam JJ,. Differences in breast cancer prognosis among African American and Caucasian women. CA Cancer J Clin. 2000; 50: 50-64. (Pubitemid 30072095)
20. Shavers VL, Brown ML,. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357. (Pubitemid 34257478)
21. Russell AH, Shingleton HM, Jones WB, et al. Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1998; 40: 605-613. (Pubitemid 28104230)
22. Merrill RM, Merrill AV, Mayer LS,. Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis. 2000; 10: 248-256.
23. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S,. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998; 71: 151-158. (Pubitemid 28550794)
24. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E,. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999; 75: 113-117. (Pubitemid 29477812)
25. Mitchell H, Medley G, Gordon I, Giles G,. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 1995; 71: 894-897.
26. Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P,. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer. 2004; 4: 1784-1786. (Pubitemid 38725653)
27. Chao A, Thomas B, Scott JW,. Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States). Cancer Causes Control. 1996; 7: 205-213. (Pubitemid 26156670)
28. Downs LS, Smith JS, Scarinci I, et al. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008; 109: S22-S30. (Pubitemid 351637605)
29. Johnson CE, Mues KE, Mayne SL, Kiblawi AN,. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis. 2008; 12: 232-241.
30. National Cancer Institute: NCI Clinical Announcement. Bethesda, MD, United States Department of Health and Human Services, Public Health Service, National Institutes of Health, February 1999.
31. Cornelison TL, Trimble EL, Kosary CL,. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol. 1999; 74: 350-355. (Pubitemid 29439872)